Traditional chemotherapies save lives but are limited by side effects. Reglagene is at the forefront of innovation by developing orally administered Precision Chemotherapies that limit toxicities and work on difficult-to-treat cancers. Precision Chemotherapy is a category of Precision Medicine, and we have found a safe way to selectively induce DNA damage in cancer cells, while leaving healthy cells alone. We aim to have our first Precision Chemotherapy entering the clinic in late 2022.
Reglagene is presenting as part of the NIH Innovation Zone.